Corcept Therapeutics (CORT) Accumulated Expenses (2010 - 2026)
Corcept Therapeutics (CORT) posted Accumulated Expenses of $115.3 million for Q2 2026, up 43.89% sequentially from $80.2 million in Q1 2026, and up 26.65% YoY from $91.1 million in Q2 2025.
Corcept Therapeutics (CORT) Accumulated Expenses (2010 - 2026) Analysis & Trends
Corcept Therapeutics has reported Accumulated Expenses for 17 years, with the latest figure at $115.3 million in Q2 2026.
- Quarterly Accumulated Expenses rose 26.65% year-over-year to $115.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $115.3 million (up 26.65% YoY) and the FY2025 annual result came in at $90.6 million, changed 0.11% from the prior year.
- Accumulated Expenses improved to $115.3 million in Q2 2026 per CORT's latest filing, from $80.2 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $115.3 million in Q2 2026 and troughed at $24.7 million in Q2 2022.
- A 5-year average of $66.3 million and a median of $64.7 million in 2023 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2023 and 2026: Accumulated Expenses surged 136.75% in 2023, then slipped 9.8% in 2026.
- Over 5 years, Accumulated Expenses stood at $30.8 million in 2022, then soared by 67.63% to $51.6 million in 2023, then soared by 75.68% to $90.7 million in 2024, then fell by 0.11% to $90.6 million in 2025, then increased by 27.31% to $115.3 million in 2026.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $115.3 million, $80.2 million, and $90.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Corcept Therapeutics | 12.37 Bn | 12.07 Bn | 252.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 115.35 Mn |
| Mar 31, 2026 | 80.16 Mn |
| Dec 31, 2025 | 90.60 Mn |
| Sep 30, 2025 | 108.45 Mn |
| Jun 30, 2025 | 91.07 Mn |
| Mar 31, 2025 | 88.88 Mn |
| Dec 31, 2024 | 90.70 Mn |
| Sep 30, 2024 | 79.46 Mn |
| Jun 30, 2024 | 59.25 Mn |
| Mar 31, 2024 | 59.74 Mn |
| Dec 31, 2023 | 51.63 Mn |
| Sep 30, 2023 | 69.63 Mn |
| Jun 30, 2023 | 52.18 Mn |
| Mar 31, 2023 | 39.09 Mn |
| Dec 31, 2022 | 30.80 Mn |
| Sep 30, 2022 | 29.41 Mn |
| Jun 30, 2022 | 24.74 Mn |
| Mar 31, 2022 | 32.66 Mn |
| Dec 31, 2021 | 27.67 Mn |
| Sep 30, 2021 | 24.31 Mn |